Skip to content
healthcare.dev
Get a free key

Sitagliptin and Metformin hydrochloride

NDC 10370-351, sitagliptin and metformin hydrochloride, tablet, film coated, extended release, from Par Health USA, LLC.

Product NDC
10370-351
Status
Listed
Labeler
Par Health USA, LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204144
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10370-351 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SITAGLIPTIN PHOSPHATE100 mg/1
  • METFORMIN HYDROCHLORIDE1000 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
10370-351-111037003511130 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (10370-351-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/43e3b1c9-3cbd-8dc3-e063-6394a90a10a2

  • NADAC price for package 10370035111

    GET /v1/drugs/nadac/10370035111

Use it

Look up 10370-351 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10370-351 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10370-351. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.